Maintenance olaparib for patients with newly diagnosed, advanced ovarian cancer and a BRCA mutation: 5-year follow-up from SOLO1
暂无分享，去创建一个
A. Oza | M. Friedlander | Byoung-Gie Kim | C. Aghajanian | A. Leary | N. Colombo | G. Scambia | A. Floquet | C. Gourley | P. DiSilvestro | G. Sonke | W. Bradley | E. Lowe | A. Oaknin | T. Cain | A. Lisyanskaya | S. Banerjee | K. Moore | A. González-Martín